Skip to main content
. 2018 Mar 28;2018:7875929. doi: 10.1155/2018/7875929

Figure 3.

Figure 3

(a–d) Computed tomography on day 73 of lenvatinib start showed that primary tumor was stable disease and there is no recurrence of pneumothorax. Thin wall cavitations were observed in the metastatic lesions (arrow).